logo

For the Inventor, By the Inventor

New York, NY, United States of America

Bantam Pharmaceutical, LLC

USPTO Granted Patents = 8

% Expired Patents = 12.5


Forward Citations = 5

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Alan B Cooper (7 out of 44 patents)

silverMedal Stephane Ciblat (5 out of 34 patents)

bronzeMedal Chantal Grand-Maitre (5 out of 10 patents)

4.  Lea Constantineau-Forget (5 out of 11 patents)

5.  Gerald W Shipps (5 out of 9 patents)

6.  M Arshad Siddiqui (4 out of 47 patents)

7.  Martin Dery (4 out of 6 patents)

8.  Nicolas Bruneau-Latour (4 out of 7 patents)

9.  Vibha Oza (3 out of 3 patents)

10.  Michael Luther (3 out of 3 patents)

11.  Jedd Levine (3 out of 3 patents)

12.  Xiangyu Guo (3 out of 3 patents)

13.  Sanjay Srivastava (3 out of 3 patents)

14.  Matthew J Kostura (2 out of 23 patents)

15.  Vu Linh Ly (2 out of 4 patents)


8 patents:

1. 12662477 - Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases (2026-06-23),
2. 12378234 - Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative (2025-08-05),
3. 12358905 - Methods for making thiazolypyrazole carboxylic acids and intermediates therefor (2025-07-15),
4. 12150934 - Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases (2024-11-26),
5. 11602526 - Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto (2023-03-14),
6. 11325903 - Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases (2022-05-10),
7. 10537558 - Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto (2020-01-21),
8. 9409901 - Compositions and methods for treating or preventing diseases or disorders associated with misregulated EIF4E (2016-08-09),
Company Overview
Bantam Pharmaceutical, LLC is a leading pharmaceutical company focused on developing innovative solutions for various medical conditions. With a team of experienced professionals, Bantam Pharma is committed to improving the quality of life for patients worldwide. Their cutting-edge research and development efforts have led to the creation of groundbreaking treatments that have the potential to revolutionize the healthcare industry.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#825 in New York, NY

#2,107 in New York

#35,941 in US

New York, NY (US)
New York, NY, United States of America

Bantam Pharmaceutical, LLC

Forward Citations = 5

22 inventors:

goldMedal Alan B Cooper (7 out of 44 patents)

silverMedal Stephane Ciblat (5 out of 34 patents)

bronzeMedal Chantal Grand-Maitre (5 out of 10 patents)

4.  Lea Constantineau-Forget (5 out of 11 patents)

5.  Gerald W Shipps (5 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bantam Pharmaceutical, LLC. Retrieved from https://idiyas.com/company/bantam-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…